CR GROUP L.P. sold 4.7% of their position (250K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $62.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/27/2023ACC: 0001209191-23-050677
-250K
Net shares
Net seller
$62.5K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
250K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−99.98K
Price / share
$0.25
Trade value
$24.99K
% of position
1.3%
9/25/2023
7.51M→7.41M
Common Stock
Indirect
Shares
−62.26K
Price / share
$0.25
Trade value
$15.56K
% of position
1.3%
9/25/2023
4.68M→4.61M
Common Stock
Indirect
Shares
−20K
Price / share
$0.25
Trade value
$5K
% of position
1.3%
9/25/2023
1.50M→1.48M
Common Stock
Indirect
Shares
−67.77K
Price / share
$0.25
Trade value
$16.94K
% of position
1.3%
9/25/2023
5.09M→5.02M
Total
Net shares
−250K
Net value
-$62.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/25/2023 | S · Sale | −99.98K | $0.25 | $24.99K | 1.3% | 7.51M | 7.41M |
| Common Stock Indirect | 9/25/2023 | S · Sale | −62.26K | $0.25 | $15.56K | 1.3% | 4.68M | 4.61M |
| Common Stock Indirect | 9/25/2023 | S · Sale | −20K | $0.25 | $5K | 1.3% | 1.50M | 1.48M |
| Common Stock Indirect | 9/25/2023 | S · Sale | −67.77K | $0.25 | $16.94K | 1.3% | 5.09M | 5.02M |
| Total | −250K | -$62.50K | ||||||
Derivative Transactions0
No derivative transactions reported